Dana-Farber Cancer Institute Enterprise Account Executive Salary
The average Dana-Farber Cancer Institute Enterprise Account Executive earns an estimated $82,864 annually, which includes an estimated base salary of $72,361 with a $10,503 bonus. Dana-Farber Cancer Institute's Enterprise Account Executive compensation is $30,610 less than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Dana-Farber Cancer Institute can range from $35,500 - $175,000.
The Business Development Department at Dana-Farber Cancer Institute earns $5,506 more on average than the Finance Department.
Last updated 7 months ago.
- $72,361
- avg. base
- $10,503
- avg. bonus
Enterprise Account Executive Salaries at Dana-Farber Cancer Institute
Enterprise Account Executives earn $2,688 more than Account Executives, and $1,339 less than Account Managers.
Compensation at Dana-Farber Cancer Institute by Department
The Business Development Department averages $5,506 more than the Finance Department, and $3,314 less than the Marketing Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Dana-Farber Cancer Institute reported making $102,476, while the average male Enterprise Account Executive at similar sized companies reported making $112,728.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Enterprise Account Executive at companies similar size to Dana-Farber Cancer Institute reported making $141,122, while the average African American/Black Enterprise Account Executive at similar sized companies reported making $73,075.
How Enterprise Account Executives at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Enterprise Account Executives at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Enterprise Account Executives at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
